# ICON plc HEOR

Source: https://en.bioecon.ru/companies/icon-plc-heor/
Updated: 2026-08-16

- Country: Ireland
- Ticker: NASDAQ:ICLR

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Headcount | 40,100 employees (2025-12-31) | https://www.biospace.com/press-releases/icon-reports-fourth-quarter-and-full-year-2025-results-and-provides-outcome-of-audit-committee-investigation |
| Revenue | $8,251.3 million (2025-12-31) | https://www.biospace.com/press-releases/icon-reports-fourth-quarter-and-full-year-2025-results-and-provides-outcome-of-audit-committee-investigation |
| Production site | Central Laboratory facilities in Farmingdale (USA), Dublin (Ireland), Singapore, and Beijing (China) | https://icon.widen.net/s/tgsbtchmjt/icon_central_laboratories-biorepository-statement-02-july-2024, https://www.iconplc.com/solutions/laboratories/global-central-laboratories/laboratory-facilities |
| Certification | CAP (College of American Pathologists), CLIA (Clinical Laboratory Improvement Amendments), NGSP, ISO 15189, and Shanghai Centre of Clinical Laboratory (SCCL) certifications/accreditations | https://icon.widen.net/s/tgsbtchmjt/icon_central_laboratories-biorepository-statement-02-july-2024, https://www.iconplc.com/solutions/laboratories/global-central-laboratories/laboratory-facilities |
| Regulatory approval | Operates under various global regulatory requirements; maintains records for inspection by regulatory authorities and clients during audits | https://investor.iconplc.com/static-files/dc127d25-0d7c-46b5-8245-2b1c7bd58f57 |
| Capacity | Operates GMP-compliant manufacturing sites for early clinical manufacturing, as well as specialized clinical research units with integrated laboratory and pharmacy infrastructure | https://www.iconplc.com/solutions/early-clinical/clinical-research-units, https://www.iconplc.com/solutions/manufacturing-pharmacy-services |

Independent sources: biospace.com, investor.iconplc.com

## Technologies

- [Health economics and outcomes research (HEOR) services](https://en.bioecon.ru/technology/heor-b2b-services/)